Innoviva
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Innoviva and other ETFs, options, and stocks.About INVA
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI.
INVA Key Statistics
Stock Snapshot
Innoviva(INVA) stock is priced at $19.51, giving the company a market capitalization of 1.46B. It carries a P/E multiple of 14.34.
On 2025-12-24, Innoviva(INVA) shares started trading at $20.02, with intraday highs of — and lows of —.
Trading volume for Innoviva(INVA) stock has reached 0, versus its average volume of 1.26M.
Over the past 52 weeks, Innoviva(INVA) stock has traded between a high of $22.76 and a low of $16.52.
Over the past 52 weeks, Innoviva(INVA) stock has traded between a high of $22.76 and a low of $16.52.
INVA News
Investors in Innoviva Inc (Symbol: INVA) saw new options begin trading today, for the December 2026 expiration. One of the key data points that goes into the pr...
Innoviva, Inc. recently received US FDA approval for NUZOLVENCE (zoliflodacin), a first-in-class, single-dose oral antibiotic to treat uncomplicated urogenital...
